Non-mevalonate pathway
The non-mevalonate pathway—also appearing as the mevalonate-independent pathway and the 2-C-methyl-D-erythritol 4-phosphate/1-deoxy-D-xylulose 5-phosphate (MEP/DOXP) pathway—is an alternative metabolic pathway for the biosynthesis of the isoprenoid precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP).[1][2][3] The currently preferred name for this pathway is the MEP pathway, since MEP is the first committed metabolite on the route to IPP.
1 Isoprenoid precursor biosynthesis
3 Inhibition and other pathway research
Isoprenoid precursor biosynthesis[edit]
The classical mevalonate pathway or HMG-CoA reductase pathway is a metabolic pathway from the biosynthesis of isoprenoid precursors present in most higher eukaryotes and some bacteria.[citation needed] It is important for the production of IPP and DMAPP, which serve as the basis for the biosynthesis of isoprenoid (terpenoid) molecules used in processes as diverse as protein prenylation, cell membrane maintenance, the synthesis of hormones, protein anchoring and N-glycosylation.[citation needed]
Bacteria, plants, and apicomplexan protozoa—such as malaria parasites—are able to produce isoprenoid precursors using an alternative pathway, the MEP pathway, which is a non-mevalonate pathway. In the case of plants and certain protozoa, the biosynthesis of IPP/DMAPP takes place in plastid organelles.[4] Plants synthesise isoprenoid precursors using the mevalonate pathway in the cytoplasm and using the MEP pathway in their chloroplasts. Bacteria that use the pathway include important pathogens such Mycobacterium tuberculosis.[5]
Non-mevalonate pathway reactions in the biosynthesis of isoprenoids. Redrawn verbatim from the scheme of Qidwai and coworkers [Fig. 2.].[6] Note, the enzyme abbreviations in this figure are non-standard (cf. Eisenreich et al.[7]), but are presented here and reproduced in the table to allow the two sets of data to be used together.
Reactions[edit]
This section relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. (March 2017)
The reactions of the non-mevalonate pathway are as follows, taken primarily from Eisenreich and co-workers, except where the bold labels are additional local abbreviations to assist in connecting the table to the scheme above:[7][6]
Reactants Enzyme Product
Pyruvate (Pyr) and glyceraldehyde 3-phosphate (G3P) DOXP synthase (Dxs; DXR) 1-Deoxy-D-xylulose 5-phosphate (DOXP; DXP)
DOXP (DXP) DXP reductoisomerase (Dxr, IspC; DXR) 2-C-methylerythritol 4-phosphate (MEP)
MEP 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (YgbP, IspD; CMS) 4-diphosphocytidyl-2-C-methylerythritol (CDP-ME)
CDP-ME 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (YchB, IspE; CMK) 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-MEP)
CDP-MEP 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase (YgbB, IspF; MCS) 2-C-methyl-D-erythritol 2,4-cyclodiphosphate (MEcPP)
MEcPP HMB-PP synthase (GcpE, IspG; HDS) (E)-4-Hydroxy-3-methyl-but-2-enyl pyrophosphate (HMB-PP)
HMB-PP HMB-PP reductase (LytB, IspH; HDR) Isopentenyl pyrophosphate (IPP) and Dimethylallyl pyrophosphate (DMAP)
Inhibition and other pathway research[edit]
DXP reductoisomerase (also known as: DXR, DOXP reductoisomerase, IspC, MEP synthase), is a key enzyme in the MEP pathway. It can be inhibited by the natural product fosmidomycin, which is under study as a starting point to develop a candidate antibacterial or antimalarial drug.[8][9][10]
The intermediate, HMB-PP, is a natural activator of human Vγ9/Vδ2 T cells, the major γδ T cell population in peripheral blood, and cells that "play a crucial role in the immune response to microbial pathogens".[11]
^ Rohmer M; Rohmer, Michel (1999). "The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants". Nat Prod Rep. 16 (5): 565–574. doi:10.1039/a709175c. PMID 10584331.
^ W. Eisenreich; A. Bacher; D. Arigoni; F. Rohdich (2004). "Review Biosynthesis of isoprenoids via the non-mevalonate pathway". Cellular and Molecular Life Sciences. 61 (12): 1401–1426. doi:10.1007/s00018-004-3381-z. PMID 15197467.
^ Hunter, WN (2007). "The Non-mevalonate Pathway of Isoprenoid Precursor Biosynthesis". Journal of Biological Chemistry. 282 (30): 21573–21577. doi:10.1074/jbc.R700005200. PMID 17442674. Retrieved March 23, 2017.
^ Lichtenthaler H (1999). "The 1-Deoxy-D-xylulose-5-phosphate pathway of isoprenoid biosynthesis in plants". Annu Rev Plant Physiol Plant Mol Biol. 50: 47–65. doi:10.1146/annurev.arplant.50.1.47. PMID 15012203.
^ Wiemer, AJ; Hsiao, CH; Wiemer, DF (2010). "Isoprenoid Metabolism as a Therapeutic Target in Gram-Negative Pathogens". Current Topics in Medicinal Chemistry. 10 (18): 1858–1871. doi:10.2174/156802610793176602. PMID 20615187.
^ a b Qidwai T, Jamal F, Khan MY, Sharma B (2014). "Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum". Biochemistry Research International. 2014: 1–12. doi:10.1155/2014/657189. PMC 4017727. PMID 24864210. CS1 maint: Uses authors parameter (link)
^ a b Eisenreich W, Bacher A, Arigoni D, Rohdich F (2004). "Biosynthesis of Isoprenoids Via the Non-mevalonate Pathway". Cell. Mol. Life Sci. 61 (12): 1401–26. doi:10.1007/s00018-004-3381-z. PMID 15197467.
^ Hale I, O'Neill PM, Berry NG, Odom A & Sharma R (2012). "The MEP pathway and the Development of Inhibitors as Potential Anti-Infective Agents" (review). Med. Chem. Commun. 3 (4): 418–433. doi:10.1039/C2MD00298A. Retrieved March 23, 2017. CS1 maint: Uses authors parameter (link)
^ Jomaa H, Wiesner J, Sanderbrand S, et al. (1999). "Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs". Science (primary research report)|format= requires |url= (help). 285 (5433): 1573–6. doi:10.1126/science.285.5433.1573. PMID 10477522.
^ C. Zinglé; L. Kuntz; D. Tritsch; C. Grosdemange-Billiard; M. Rohmer (2010). "Isoprenoid Biosynthesis via the Methylerythritol Phosphate Pathway: Structural Variations around Phosphonate Anchor and Spacer of Fosmidomycin, a Potent Inhibitor of Deoxyxylulose Phosphate Reductoisomerase". J. Org. Chem. (primary research report)|format= requires |url= (help). 75 (10): 3203–3207. doi:10.1021/jo9024732. PMID 20429517.
^ Eberl M, Hintz M, Reichenberg A, Kollas AK, Wiesner J, Jomaa H (2003). "Microbial Isoprenoid Biosynthesis and Human γδ T cell Activation". FEBS Lett. 544 (1–3): 4–10. doi:10.1016/S0014-5793(03)00483-6. PMID 12782281.
Hale I, O'Neill PM, Berry NG, Odom A & Sharma R (2012). "The MEP pathway and the Development of Inhibitors as Potential Anti-Infective Agents" (review). Med. Chem. Commun. 3 (4): 418–433. doi:10.1039/C2MD00298A. Retrieved March 23, 2017. CS1 maint: Uses authors parameter (link) RSC review; uses MAP synthase nomenclature.
Qidwai T, Jamal F, Khan MY, Sharma B (2014). "Exploring Drug Targets in Isoprenoid Biosynthetic Pathway for Plasmodium falciparum". Biochemistry Research International. 2014: 1–12. doi:10.1155/2014/657189. PMC 4017727. PMID 24864210. CS1 maint: Uses authors parameter (link)
Metabolism - non-mevalonate pathway enzymes
DXP synthase
DXP reductoisomerase
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol kinase
4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase
4-hydroxy-3-methylbut-2-enyl diphosphate reductase
Metabolism map
Photo-
Pentose
acid cycle
Glyoxylate
Peroxisomal
Glyco-
genolysis
lysis
Gluconeo-
decarb-
oxylation
Keto-
feeders to
Direct / C4 / CAM
carbon intake
Light reaction
Oxidative
deamination
Lipogenesis
Steroidogenesis
MVA pathway
MEP pathway
Transcription &
Proteolysis
Glycosyl-
ation
Double/multiple
sugars & glycans
Inositol-P
Amino sugars
& sialic acids
Nucleotide sugars
Hexose-P
Triose-P
P-glycerates
Pentose-P
Tetrose-P
Propionyl
-CoA
Acetyl
Photosystems
Oxalo-
Succinyl
α-Keto-
glutarate
Ketone
Serine group
Branched-chain
& lysine
Glutamate
& proline
& polyamines
Ketogenic &
glucogenic
Aromatic amino
acids & histidine
Ascorbate
(vitamin C)
δ-ALA
Hemes
Cobalamins (vitamin B12)
vitamin Bs
Calciferols
(vitamin D)
Retinoids
(vitamin A)
Quinones (vitamin K)
& carotenoids (vitamin E)
Cofactors
& minerals
PRPP
Nucleic
& proteoglycans
Chlorophylls
Polyketides
Terpenoid
backbones
Terpenoids
& carotenoids (vitamin A)
Bile acids
Glycero-
phospholipids
Glycerolipids
Acyl-CoA
sphingolipids
& thyroid hormones
Endo-
Eicosanoids
Major metabolic pathways in metro-style map. Click any text (name of pathway or metabolites) to link to the corresponding article.
Single lines: pathways common to most lifeforms. Double lines: pathways not in humans (occurs in e.g. plants, fungi, prokaryotes). Orange nodes: carbohydrate metabolism. Violet nodes: photosynthesis. Red nodes: cellular respiration. Pink nodes: cell signaling. Blue nodes: amino acid metabolism. Grey nodes: vitamin and cofactor metabolism. Brown nodes: nucleotide and protein metabolism. Green nodes: lipid metabolism.
Cholesterol and steroid metabolic intermediates
Mevalonate pathway
to HMG-CoA
Acetyl-CoA
Acetoacetyl-CoA
HMB-CoA
HMG-CoA
Ketone bodies
Acetoacetic acid
β-Hydroxybutyric acid
to DMAPP
Mevalonic acid
Phosphomevalonic acid
5-Diphosphomevalonic acid
Isopentenyl pyrophosphate
Dimethylallyl pyrophosphate
Geranyl-
Geranyl pyrophosphate
Geranylgeranyl pyrophosphate
Carotenoid
Prephytoene diphosphate
Phytoene
DOXP
CDP-ME
CDP-MEP
MEcPP
HMB-PP
DMAPP
To Cholesterol
Farnesyl pyrophosphate
2,3-Oxidosqualene
Lanosterol
Lathosterol
7-Dehydrocholesterol
7-Dehydrodesmosterol
Desmosterol
From Cholesterol
(to steroids)
22R-Hydroxycholesterol
20α,22R-Dihydroxycholesterol
Steroid hormones
Nonhuman
Stigmasterol
Ergosterols
Ergocalciferol
Retrieved from "https://en.wikipedia.org/w/index.php?title=Non-mevalonate_pathway&oldid=899176366"
CS1 maint: Uses authors parameter
Pages using citations with format and no URL
Articles needing additional references from March 2017